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Introduction {#sec1}
============

Growth regulation is a critical developmental process whose dysfunction can lead to many diseases, including cancer ([@bib6]). The Salvador (Sav)/Warts (Wts)/Hippo (Hpo) (SWH) network, identified in *Drosophila* and conserved in mammals, plays a major role in limiting growth by inhibiting cell proliferation and promoting apoptosis ([@bib12; @bib27]). Activation of the upstream kinase Hpo allows it to phosphorylate the downstream kinase Wts, which in turn phosphorylates and inhibits the transcription coactivator Yorkie (Yki). Scaffold proteins, such as Salvador (Sav) and Mats, potentiate the activity of the Hpo/Wts complex ([@bib12]). One upstream input of the pathway is mediated via Merlin (Mer) and Expanded (Ex), two FERM (Four point one, Ezrin, Moesin, Radixin) domain proteins ([@bib11]). Recently, Ex was shown to bind Yki, and new experiments hint at the existence of an Ex/Hpo/Wts-containing apical complex anchoring Yki at the cortex ([@bib1; @bib22]). These findings underline the importance of scaffold proteins in the regulation of the pathway. However, though some upstream members are known, how the SWH network is activated remains unclear.

Here, we identify the WW-domain-containing protein Kibra as a regulator of the SWH network. Human KIBRA ([@bib15]) is known to be phosphorylated by Protein Kinase C ζ (PKCζ) ([@bib4]) and has recently been reported to have a role in cell migration ([@bib8; @bib29]). In *Drosophila*, Kibra had previously been recovered as a minor hit in several screens for growth regulators ([@bib2; @bib20; @bib28; @bib32]) but has not been further studied. Our experiments show that Kibra associates with Mer, Ex, and Wts and stabilizes the Mer/Ex interaction. This suggests that Kibra is a component of an apical scaffold that controls SWH pathway activation.

Results {#sec2}
=======

*kibra* and *wts* RNAi Depletion Induce Similar Overgrowth Phenotypes {#sec2.1}
---------------------------------------------------------------------

We performed an in vivo screen in the fly wing in order to identify genes implicated in growth control. Transgenic flies bearing RNA interference (RNAi) constructs generated by the Vienna *Drosophila* RNAi Centre (VDRC) ([@bib7]) were crossed to the *hedgehog-GAL4* (*hh-GAL4*) driver, leading to target gene silencing in the posterior compartment of the wing. We screened a collection of 12,000 lines targeting genes conserved between *Drosophila* and mammals. The results of this screen will be described elsewhere.

In this context, expressing an RNAi line directed against *kibra* induced overgrowth of the posterior wing compartment ([Figure 1](#fig1){ref-type="fig"}B) compared to control flies ([Figure 1](#fig1){ref-type="fig"}A). This phenotype was also observed upon *wts* depletion ([Figure 1](#fig1){ref-type="fig"}C). Driving the same *kibra* RNAi line in the eye also led to increased organ size ([Figures 1](#fig1){ref-type="fig"}D and 1E), similarly to a *wts* RNAi line ([Figure 1](#fig1){ref-type="fig"}F). To exclude off-target effects, we generated a transgenic line expressing a nonoverlapping RNAi construct and observed identical overgrowth phenotypes (data not shown). Furthermore, adult eye sections revealed that *kibra* knockdown retinas present an excess of interommatidial cells (IOCs) ([Figures 1](#fig1){ref-type="fig"}G and 1H). The IOCs, the last population of cells to differentiate in the eye primordium, give rise to the secondary and tertiary pigment cells that optically isolate the ommatidia in the compound eye from each other. Extra IOCs are produced during normal development but are then eliminated by apoptosis at the pupal stage to give rise to the adult lattice ([@bib35]). The presence of extra IOCs is a hallmark of SWH network loss of function ([@bib14; @bib31]), which reduces retinal apoptosis, as seen in *wts* RNAi adult eye sections ([Figure 1](#fig1){ref-type="fig"}I). Thus, depletion of *kibra* elicits a similar phenotype to SWH network mutants, suggesting a potential role for Kibra in Hpo signaling.

*kibra* Loss of Function Causes Excess Proliferation and a Reduced Apoptotic Rate, Similarly to SWH Network Loss of Function {#sec2.2}
----------------------------------------------------------------------------------------------------------------------------

To study *kibra* loss of function, we generated the *kibra^Δ32^* allele by imprecise excision of the *EP747* transposon (see [Figure 1](#fig1){ref-type="fig"}J and [Experimental Procedures](#sec4){ref-type="sec"}). This deletion allele, which removes the translation initiation site, is homozygous lethal and may be a null allele for *kibra*. *kibra^Δ32^* FLP/FRT mutant clones in 40 hr after-puparium-formation (APF) retinas present extra IOCs ([Figure 1](#fig1){ref-type="fig"}K--1M), similarly to what was observed in adult eyes with *kibra* knockdown ([Figures 1](#fig1){ref-type="fig"}G--1I). Duplication of bristles or missing bristles can also be observed. We determined apoptotic indexes ([@bib5]) during the retinal apoptosis wave (28 hr APF) in pupal retinas containing *kibra* mutant clones stained with an anti-active Caspase-3 antibody. *kibra* mutant tissue presents a reduced apoptotic index compared with *wild-type* (WT) areas in the same retinas ([Figures 1](#fig1){ref-type="fig"}N--1P; see [Figures S1](#app2){ref-type="sec"}A--S1A″′ available online). Thus, extra IOCs persist in *kibra* mutant clones as a result of decreased developmental apoptosis.

We assessed the proliferation rate of *kibra* mutant cells in imaginal discs, the larval precursors to the adult appendages. By using the FLP/FRT system under the control of the *heat-shock* promoter, *kibra* mutant cells and their WT sister clones were generated through single recombination events from heterozygous mother cells ([@bib3]). After several rounds of divisions, the sizes of mutant clones (no GFP) and WT twin spots (two copies of GFP) were compared, allowing us to estimate the relative proliferation rates of mutant versus WT cells. The total *kibra* clone area is 1.57 (±0.12)-fold larger than the control twin spot area, compared to a ratio of 0.98 (±0.09) when both clones and twin spots are WT ([Figures 1](#fig1){ref-type="fig"}Q--1S), indicating that *kibra^Δ32^* mutant cells grow 1.6 times faster than WT cells.

In addition to cell cycle rates, the timing of cell cycle exit can readily be measured in the eye disc, where cell divisions follow a spatially determined pattern ([@bib35]). During the third larval instar, the morphogenetic furrow, a wave of differentiation, sweeps the eye disc from posterior to anterior. Anterior to the furrow cells still proliferate asynchronously, while in the furrow cells synchronize in G1. Immediately posterior to the furrow, cells enter a final round of synchronous S phases, the second mitotic wave (SMW). Posterior to the SMW, most cells permanently exit the cell cycle. Thus, in WT discs, no S phases (marked by EdU incorporation) can be observed posterior to the SMW ([Figure 1](#fig1){ref-type="fig"}T). As expected, *hpo* mutant cells fail to exit from the cell cycle in a timely manner and present ectopic EdU-positive staining posterior to the SWM ([Figures S1](#app2){ref-type="sec"}B and S1B′). *kibra* mutant cells exhibit a less pronounced but similar phenotype ([Figures 1](#fig1){ref-type="fig"}U and 1V). Thus, *kibra* mutant tissues have a proliferative advantage and an apoptosis defect, consistent with an involvement in the SWH network. The overgrowth defect appears more subtle than that of core pathway members such as *wts* and is more akin to upstream regulators (e.g., *ex* and *mer*).

Kibra Regulates SWH Network Targets in Ovarian Posterior Follicle Cells {#sec2.3}
-----------------------------------------------------------------------

Several transcriptional targets of the SWH network have been identified, such as the *Drosophila Inhibitor of Apoptosis 1* (*DIAP1*) gene, the cell cycle regulator *cycE*, the miRNA *bantam,* as well as *ex* ([@bib12; @bib30]). In *kibra* mutant wing or eye discs, we could not detect a strong change in DIAP1, CycE, or *ex-lacZ* reporter levels (data not shown). Since overgrowth of *kibra* mutant cells in the wing is subtle compared to *wts* mutants, it is possible that Kibra plays a relatively minor role in SWH signaling in the wing. Accordingly, using an anti-Kibra antibody we generated ([Figures S2](#app2){ref-type="sec"}A--S2C), we noted that Kibra staining in the wing disc is weak and consists of a punctate apical staining which can clearly be observed when *kibra* is overexpressed in a stripe of cells. Thus, the extent to which Kibra is required may vary in different tissues.

We and others have previously reported that ovarian posterior follicle cells (PFCs) are particularly sensitive to SWH loss of function ([@bib19; @bib24; @bib36]), leading us to study the *kibra^Δ32^* phenotype in the ovary. First, we noted that Kibra protein levels are higher in follicle cells than in the wing discs ([Figure S2](#app2){ref-type="sec"}D--S2E′). Kibra staining is mainly apical and is severely reduced in *kibra^Δ32^* clones. Similarly to *hpo* or *wts* loss of function, *kibra* loss of function in the PFCs induces an upregulation of the *ex*-*lacZ* reporter ([Figures 2](#fig2){ref-type="fig"}A--2B″, compare with [Figures 2](#fig2){ref-type="fig"}C--2C″). *hpo* or *wts* mutant PFCs also show a misregulation of the Notch (N) pathway and ectopic cell divisions ([@bib19; @bib24; @bib36]). The N target Hindsight (Hnt) is normally repressed in all follicle cells up to stage 6 and switched on from stage 7 to stage 10B ([Figures 2](#fig2){ref-type="fig"}D--2E″) ([@bib26]). Cut, which is repressed by Hnt, presents an opposite pattern of expression ([Figures 2](#fig2){ref-type="fig"}H--2I″). In *kibra* mutant PFCs from stage 7--10B egg chambers, Hnt expression is lost ([Figures 2](#fig2){ref-type="fig"}D--2D″ and 2F--2G″), while Cut is ectopically expressed ([Figures 2](#fig2){ref-type="fig"}J--2K″). This indicates that N signaling is downregulated in *kibra* mutant PFCs. Loss of *kibra* also leads to perturbation of epithelial integrity, as mutant PFCs show an accumulation of the apical polarity protein aPKC and the N receptor ([Figures S2](#app2){ref-type="sec"}F--S2G″) as well as multilayering of the follicular epithelium ([Figures 2](#fig2){ref-type="fig"}I--2I″ and 2K--2K″). Ectopic mitotic divisions are also observed in PFCs clones after stage 6, as detected by phospho-histone H3 (PH3) staining ([Figures S2](#app2){ref-type="sec"}H--S2H″). Together, these phenotypes are identical to those observed in *hpo* or *wts* loss of function, suggesting that Kibra is indeed a member of the SWH network.

Genetic Experiments Place *kibra* Upstream of the Core SWH Kinase Cassette {#sec2.4}
--------------------------------------------------------------------------

To further explore the role of Kibra in the SWH network, genetic interaction and epistasis experiments were performed. Overexpressing *kibra* in the eye under the *GMR (Glass Multimer Reporter)* promoter elicits the formation of a small rough eye with frequent ommatidial fusions ([Figures S3](#app2){ref-type="sec"}A--S3B′). This phenotype can be partially rescued by removing one copy of the *hpo* gene ([Figures S3](#app2){ref-type="sec"}C and S3C′). In contrast, overexpressing *kibra* could not rescue the *hpo*-like overgrowth phenotype induced by *yki* overexpression ([Figures S3](#app2){ref-type="sec"}D and S3E), suggesting that Kibra may be an upstream regulator of the pathway.

To conduct epistasis experiments between *kibra* and *yki*, we used the MARCM system to generate clones of mutant cells while simultaneously overexpressing or depleting other pathway components ([@bib17]). MARCM clones expressing *yki* RNAi generated with *eyFLP* lead to the formation of a normal eye, because *yki*-depleted cells are eliminated by apoptosis (data not shown) and replaced by WT cells ([Figure S3](#app2){ref-type="sec"}F). As expected, *eyFLP kibra* MARCM clones cause eye overgrowth ([Figure S3](#app2){ref-type="sec"}G). This overgrowth is rescued by *yki* depletion in the mutant cells ([Figure S3](#app2){ref-type="sec"}H), indicating that the *kibra* overgrowth phenotype is *yki* dependent. Furthermore, overexpressing *kibra* in the eye under the *GMR* promoter induces apoptosis in third instar eye discs, which is suppressed by loss of *hpo* ([Figures 3](#fig3){ref-type="fig"}A--3A″). Together, these epistasis experiments are consistent with Kibra being a member of the SWH network acting upstream of Yki and Hpo.

Genetic interactions between *kibra*, *mer*, and *ex*, upstream members of the SWH network, were then investigated. Expressing a *kibra*, an *ex,* or a *mer* RNAi line in the eye under the *GMR* promoter induces eye overgrowth ([Figures S3](#app2){ref-type="sec"}I--S3L). Combined depletion of either Ex/Kibra or Mer/Kibra shows stronger phenotypes than individual depletion of these proteins ([Figures S3](#app2){ref-type="sec"}M and S3N). We used the MARCM technique to evaluate epistatic relationships between those three genes. *hsFLP* MARCM clones of various genotypes were generated and scored according to the severity of the wing overgrowth phenotypes, with type 0 representing normal wings and type 4 the strongest overgrowth ([Figures 3](#fig3){ref-type="fig"}B and 3C). Overexpressing *ex* or *mer* in *kibra* mutant clones significantly rescues the overgrowth of *kibra* mutant clones (p \< 0.0001 for both genotypes). Reciprocally, *kibra* overexpression was also able to suppress the *ex* overgrowth phenotype (p \< 0.0001). Thus, we could not determine a strict epistatic relationship between *kibra*, *ex*, and *mer*, consistent with a model whereby *kibra*, *ex*, and *mer* cooperate to control SWH pathway activity.

Kibra Is a Transcriptional Target of the SWH Network and Colocalizes with Mer and Ex {#sec2.5}
------------------------------------------------------------------------------------

As well as being an upstream regulator of the SWH network, *ex* is also one of its transcriptional targets ([@bib11]), as are other upstream regulators (e.g., *mer*, *four-jointed*, *dachsous*). Since epistasis experiments place Kibra at the level of Mer and Ex, we wished to test whether this is also the case for *kibra*. Kibra levels were highly upregulated in *mer;ex* or *hpo* clones ([Figures 3](#fig3){ref-type="fig"}D--3E′), showing an apical localization ([Figures 3](#fig3){ref-type="fig"}F--3G′). The same is true in *hpo* clones in follicle cells ([Figures 3](#fig3){ref-type="fig"}H--3I″). Similarly, *hpo*-depleted cultured *Drosophila* S2R+ cells have increased Kibra levels ([Figure 3](#fig3){ref-type="fig"}J). To determine whether *kibra* is a transcriptional SWH network target, quantitative RT-PCR experiments were performed on *yki*-overexpressing and control wing imaginal discs ([Figure 3](#fig3){ref-type="fig"}K). As expected, *ex* mRNA levels were increased (2.97 ± 0.25-fold) in *yki*-expressing discs compared to control discs. Interestingly, *kibra* mRNA levels were also upregulated in *yki*-expressing discs (6.24 ± 2.12-fold), confirming that *kibra* is a Yki transcriptional target and suggesting the existence of a possible negative feedback loop regulating Kibra expression.

Because *hpo* clones present increased levels of Kibra as well as Mer and Ex, these constitute a good system to evaluate the colocalization of those proteins. Indeed, Kibra colocalizes with Mer in the wing disc ([Figures 3](#fig3){ref-type="fig"}L--3M″). As expected, Mer and Ex also colocalize ([Figures 3](#fig3){ref-type="fig"}N--3O″). Thus, Kibra, Mer, and Ex colocalize apically in imaginal disc cells, but are dispensable for each other\'s apical sorting, because Kibra is still apical in *mer;ex* clones and Mer/Ex are normally localized in *kibra* clones ([Figures 3](#fig3){ref-type="fig"}D, 3D′, 3F, and 3F′ and data not shown).

Kibra Associates with Ex and Mer, and the Kibra/Mer Complex Is Conserved in Human Cells {#sec2.6}
---------------------------------------------------------------------------------------

Because Kibra colocalizes with Mer/Ex, a possible association between those proteins was examined by conducting coimmunoprecipitation (co-IP) assays in S2R+ cells. Kibra was found to co-IP with Ex and Mer, but not with Hpo or with the negative regulator of Hpo, dRASSF ([@bib25]) ([Figure 4](#fig4){ref-type="fig"}A). Interestingly, Kibra was reported to interact with Mer in a large-scale yeast two-hybrid screening study ([@bib9]). Kibra possesses two WW domains, which are predicted to mediate protein-protein interactions by binding to PPXY motifs. Furthermore, the first WW domain of human KIBRA was shown to recognize the consensus motif RXPPXY in vitro ([@bib15]). In flies, Mer does not contain any PPXY sites, while Ex has two PPXY sites (P^786^PPY and P^1203^PPY) and an RXPPXY site (R^842^DPPPY). We therefore further investigated the association between Kibra and Ex by mutating amino acids that are known to be required for WW domains and PPXY sites to interact ([@bib15; @bib23]). A Kibra protein mutant for its first WW domain (P85A) could no longer co-IP WT Ex. Reciprocally, WT Kibra could not co-IP an Ex protein deficient for its RXPPXY site (P845A) ([Figure 4](#fig4){ref-type="fig"}B). Thus, Kibra associates with Ex through its first WW domain and the Ex RXPPXY motif.

In contrast, mutating either one or both Kibra WW domains does not affect Kibra/Mer association ([Figure S4](#app2){ref-type="sec"}A). Further assays reveal that both Kibra N- and C-terminal fragments are sufficient for the association with Mer, but a central stretch (aa 484--857) is not ([Figure S4](#app2){ref-type="sec"}A). Because the WW motifs, which are required for the Ex/Kibra association, are located in the N-terminal fragment, this suggests that Mer can complex with Kibra both through Ex and independently of Ex. To further test this possibility, coimmunoprecipitation assays between Mer and Kibra were performed in *ex*-depleted cells ([Figure S4](#app2){ref-type="sec"}B). The Kibra/Mer immunoprecipitation is not affected by *ex* depletion, suggesting that Ex is not required for the Kibra/Mer association.

Because the Hpo pathway is highly conserved from *Drosophila* to humans, we tested for potential interactions between human KIBRA and the human orthologs of Ex (FRMD6), Mer (NF2/MER), Hpo (MST2), and dRASSF (RASSF6). We used split-TEV as readout, which is based on TEV protease complementation and represents a sensitive method for detecting interactions between membrane-associated proteins ([@bib33; @bib34]). We found that KIBRA associates with NF2/MER but did not interact with FRMD6, MST2, or RASSF6 ([Figure S4](#app2){ref-type="sec"}C). Interestingly, FRMD6 contains only an N-terminally conserved sequence of Ex but lacks the entire C-terminal part, which in Ex harbors the PPXY motifs. Thus, the missing PPXY motifs and the generally limited level of sequence conservation in FRMD6 likely explain the absence of interaction between KIBRA and FRMD6. These results imply that the ability to associate with Kibra evolved in an ancestral Ex/Mer-like FERM domain protein and was later lost in FRMD6 but retained in NF2/MER. Alternatively, an Ex functional homolog other than FRMD6 may exist.

As Kibra complexes with both Ex and Mer and Ex/Mer have been reported to directly interact ([@bib18]), we tested the possibility that Kibra could affect the Mer/Ex interaction. We performed co-IP assays between Mer and Ex in cells expressing different levels of Kibra protein ([Figure 4](#fig4){ref-type="fig"}C). The Mer/Ex interaction is reduced in *kibra*-depleted cells compared to WT cells, whereas the interaction is strengthened in cells that express a Myc-Kibra construct. Thus, the presence of Kibra is required to fine-tune the stability of the Mer/Ex interaction.

Kibra Associates with Wts and Is Required for Yki Phosphorylation, but Not for Yki/Wts Binding {#sec2.7}
----------------------------------------------------------------------------------------------

Because Kibra complexes with Ex and a Yki/Ex interaction has recently been described ([@bib1]), we sought to determine whether Kibra can affect Yki activity. S2R+ cells were treated with RNAi against several SWH pathway components, and Yki phophorylation on Ser168 was monitored by western blotting ([Figure 4](#fig4){ref-type="fig"}D). The phosphorylation of Yki by Wts at Ser168 leads to Yki inactivation and sequestration in the cytoplasm, where it has been reported to bind Ex, Wts, Hpo, and 14.3.3 ([@bib1; @bib13; @bib21; @bib22]). *lacZ* RNAi-treated cells show a high basal level of phospho-Yki (P-Yki). As expected, Yki phosphorylation is abolished when Wts is depleted, and mildly reduced when the Wts cofactor Mats ([@bib16]) is depleted. In *wts* treated RNAi cells, a Yki downward shift can also be observed using a pan-Yki antibody ([Figure 4](#fig4){ref-type="fig"}D, second row). *ex* RNAi treatment has only a mild effect on P-Yki levels. Interestingly, *kibra* depletion leads to a marked reduction in P-Yki. When depleted in conjunction with *ex*, the P-Yki signal becomes even further reduced.

This suggests that Kibra and Ex are required for Wts activity on Yki, which prompted us to investigate whether Kibra could associate with Wts. Co-IP assays reveal that Kibra interacts with Wts ([Figure 4](#fig4){ref-type="fig"}E). Wts does not seem to compete with Ex for Kibra association, because it could still complex with a form of Kibra mutant for its first WW domain. Because Kibra associates with Wts and Ex interacts with Yki, we investigated whether Wts requires Kibra/Ex to bind Yki. Endogenous IPs between Yki and Wts were performed in S2 cells treated with various dsRNAs ([Figure 4](#fig4){ref-type="fig"}F). In these conditions, the effect of *kibra* and *ex* depletion on Yki phosphorylation can also be observed (see input). In control cells, Wts binding to Yki is detected after immunoprecipitating Yki. This endogenous interaction is unaffected by the individual or combined depletion of *ex* and *kibra*. These results suggest that Ex and Kibra are required to activate the SWH pathway by nucleating an active Hpo/Wts kinase cassette, rather than promoting the Wts/Yki interaction.

Discussion {#sec3}
==========

Our data identify Kibra as a regulator of the SWH network that associates with Ex and Mer, with which it is colocalized apically and transcriptionally coregulated. Given that the apical surface of epithelial cells is instrumental in both cell-cell signaling and tissue morphogenesis, we speculate that Kibra may cooperate with Ex and Mer to transduce an extracellular signal, or relay information about epithelial architecture, via the SWH network, to control tissue growth and morphogenesis.

Recent data have suggested that an apical scaffold machinery containing Hpo, Wts, and Ex recruits Yki to the apical membrane, facilitating its inhibitory phosphorylation by Wts ([@bib1; @bib22]). Since Kibra associates with Ex and is also apically localized, we can hypothesize that Kibra is also part of this scaffold and participates in nucleating an active Hpo/Wts complex and recruiting Yki for inactivation. This view is supported by our finding that Kibra complexes with Wts and that combined depletion of Kibra and Ex leads to a strong decrease in Yki phosphorylation, but does not disrupt the Wts/Yki interaction. Our data also suggest that the importance of Kibra may be tissue-specific since we observe robust phenotypes in ovaries and hemocyte-derived S2R+ cells, but weaker effects in imaginal discs. Thus, considering the relative levels of expression of Ex, Mer, and Kibra may be important in determining pathway activation. Finally, since mammalian KIBRA complexes with the NF2/MER tumor suppressor, our findings raise the possibility that human KIBRA may contribute to tumor suppression in human neurofibromas and potentially other tumors.

Experimental Procedures {#sec4}
=======================

For *Drosophila* genotypes, primer sequences, and further experimental details, see [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

*kibra* Mutant {#sec4.1}
--------------

The P element of *EP747* (Bloomington stock center) was mobilized using standard genetic techniques, and excisions were screened by PCR (see [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details).

Immunostainings {#sec4.2}
---------------

Immunostainings and confocal image acquisitions were performed as in [@bib10]. Mouse β-galactosidase (Promega), rabbit anti-Cleaved Caspase-3 (Asp175) (Cell Signaling Technology), rabbit anti-aPKC (Santa Cruz), and mouse NICD (C17.9C6, Development Studies Hybridoma Bank) antibodies were used at 1/500. Mouse anti-Arm, anti-Cut, and anti-Hnt (N2 7A1, 2B10 and 1G9, DSHB) were used at 1/10 and 1/20. The EdU staining was performed as described in the Click-iT EdU Alexa Fluor Imaging Kit (Invitrogen). Guinea pig anti-Mer, a gift from R. Fehon, was used at 1/7500, and rabbit anti-Ex, a gift from A. Laughon, at 1/400. Rabbit anti-Kibra antibody (Kib18, 1/100) was generated by Eurogentec SA (Seraing, Belgium) against a peptide corresponding to the last 15 amino acids of Kibra.

Quantification of Apoptotic Indexes in Mutant Clones versus WT Tissue {#sec4.3}
---------------------------------------------------------------------

Apoptotic indexes were quantified on 6 retinas as described in [@bib5].

Standard Growth Conditions and Size Measurements {#sec4.4}
------------------------------------------------

The experiment was performed as described in [@bib10]. Ten wing discs for each genotype were analyzed.

Fly Eye Scanning Electron Microscopy {#sec4.5}
------------------------------------

Scanning microscopy of adult flies was performed as described in [@bib25].

RNAi Treatment and Coimmunoprecipitation of Proteins {#sec4.6}
----------------------------------------------------

For RNAi treatment, S2 or S2R+ cells were treated with dsRNAs as indicated for 4 days. For coimmunoprecipitations, S2R+ or S2 cells transfected with the indicated plasmids were used. See [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details.

Quantitative RT-PCR {#sec4.7}
-------------------

*MS1096 \> \>* (control) and *MS1096 \> \> yki* wing discs were dissected in PBS and snap-frozen in liquid nitrogen. RNA isolation and subsequent qRT-PCR reactions were performed as described in [@bib10]. See [Supplemental Experimental Procedures](#app2){ref-type="sec"} for primer sequences.

Statistical Analysis {#sec4.8}
--------------------

All error bars displayed represent standard deviations. All statistical analyses performed (except epistasis analysis) were assessed by Mann-Whitney nonparametric tests using the website [http://elegans.swmed.edu/∼leon/stats/utest.html](http://elegans.swmed.edu/~leon/stats/utest.html).

The epistasis analysis was made by pairwise comparison after correction for the batch effect on 42 to 310 flies of each genotype, divided in 4 to 6 cohorts. The approach used was a three-way log-linear model, against a null-hypothesis of no interaction between phenotype and population. The p value indicates whether the pair of populations differ in their phenotype profiles: p value(*kibra^−/−^; kibra^−/−^ + UAS ex*) = 2.69 × 10^−63^, p value(*kibra^−/−^; kibra^−/−^ +UAS mer*) = 6.07 × 10^−35^, p value(*ex^−/−^; ex^−/−^ + UAS kibra*) = 1.76 × 10^−20^.

Supplemental Information {#app2}
========================
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![Kibra Loss of Function Induces a Phenotype Similar to SWH Network Loss of Function\
(A--C) Control wings (A) and wings where the *kibra* (B) or *wts* (C) genes were silenced by RNAi in the posterior compartment (red dotted line).\
(D--I) Control fly eyes (D and G) and eyes expressing the same RNAi lines against *kibra* (E and H) or *wts* (F and I). In adult eye sections (G--I), interommatidial cells (IOCs) are in red and photoreceptors in blue.\
(J) Schematic of the *kibra* locus showing the localization of the *kibra^Δ32^* allele, generated by excision of the *EP747* P element (triangle). The coding sequence is in red; 5′- and 3′-UTRs are in blue. In black is the peptide recognized by the Kib18 antibody.\
(K--M) 40 hr APF retinas containing *kibra* mutant clones. (K and L) Cell outlines are visualized by anti-Arm staining (scale bar = 10 μm). (M) Quantification of the IOCs. The p value from a Mann-Whitney test is shown.\
(N--P) Apoptotic index in 28 hr APF retinas containing *kibra* mutant clones (absence of GFP). A retina stained for activated Caspase-3 (Cas3) merged with GFP is shown in (N). The Cas3 staining for the whole retina is shown in (O). (P) Quantification of the apoptotic index. The p value from a Mann-Whitney test is shown.\
(Q--S) Wing disc (Q) and eye disc (R) containing *kibra* clones (lack of GFP). Scale bars = 20 μm. (S) Quantification of the proliferation advantage of WT or *kibra* mutant cells by calculating the ratio between total clonal area (no GFP) and total twin spot area (two copies of GFP) for discs containing either WT or *kibra* clones. The p value from a Mann-Whitney test is shown.\
(T--V) EdU labeling (shown in gray or red) of WT discs (T) and of discs containing *kibra* clones (U and V). Posterior is to the right, and the SMW is indicated by a red arrowhead. See also [Figure S1](#app2){ref-type="sec"}.\
Error bars represent standard deviations.](gr1){#fig1}

![Kibra Regulates SWH Pathway Targets in Ovarian Posterior Follicle Cells\
Egg chambers containing heat-shock-induced *kibra* mutant clones (absence of GFP). Yellow arrows point to *kibra* mutant cells in the PFC region while white arrowheads point to *kibra* cells in lateral follicle cells. Scale bars = 20 μm. (A--C′) Stage 10B egg chambers stained for β-galactosidase (gray or red), which monitors the activity of the *ex-lacZ* reporter. (B--B″) Close-up of the PFC region in (A)--(A″). (D--K″) Egg chambers stained for the N target Hindsight (Hnt) (D--G″) or for Cut (H--K″). Nuclei are shown in blue (Hoechst). (E)--(E″), (G)--(G″), (I)--(I″), and (K)--(K″) are close-ups of the PFC region of stage 10B egg chambers. (D--D″) The arrow points to a stage 8 clone; the arrowhead points to a stage 9 clone. (F--F″ and J--J″) Arrows and arrowheads point to clones in stage 9 egg chambers. See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![*kibra* Is Epistatic to *hpo* and Is a Transcriptional Target of the SWH Network\
(A--A″) Third instar eye imaginal disc expressing *kibra* under the *GMR* promoter and containing *hpo* mutant cells (absence of GFP). Apoptosis is visualized by an anti-activated Caspase-3 staining. Posterior is to the bottom.\
(B and C) Epistatic relationships between Kibra, Mer and Ex. Examples of the 4 phenotypic classes used to score are shown in (B). The percentages of each class for each genotype are summarized in (C).\
(D--G′) Third instar imaginal discs containing clones (marked by absence of GFP) of cells mutant for *mer;ex* (D, D′, F, and F′) or *hpo* (E, E′, G, and G′). (D)--(E′) are XY sections while (F)--(G′) are XZ transverse sections (apical is to the top).\
(H--I″) Stage 10A egg chamber containing a *hpo* clone (marked by absence of GFP) in the PFCs and stained for Kibra (red). (I)--(I″) show a higher magnification of the PFC region in (H). Nuclei are stained with Hoechst (blue). Scale bars = 20 μm (A--A″, D--E′, and H), 10 μm (F--G′ and I--I″).\
(J) Lysates from S2R+ cells treated with *lacZ* RNAi or *hpo* RNAi and probed for Kibra and Tubulin.\
(K) A graph presenting a comparison of *kibra* and *ex* mRNA levels between *yki* overexpressing and WT wing discs, as measured by qRT-PCR, is shown. p values from Mann-Whitney tests are shown. Error bars represent standard deviations.\
(L--O″) XY and transverse sections of third instar imaginal wing discs containing *hpo* mutant clones (labeled by absence of βgal) and stained for Kibra (L--L″ and N--N″), Ex (M--M″ and O--O″), and Mer (L--O″). See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![Kibra Associates with Mer and Ex, and *kibra* Depletion Strongly Reduces Yki Phosphorylation without Interfering with the Yki/Wts Interaction\
(A and B) Western blots of coimmunoprecipitation assays between Myc-Kibra and HA-tagged members of the SWH network are shown.\
(C) Western blots of co-IP assays between Mer-HA and Ex-Flag in presence or absence of Kibra are shown.\
(D) Lysates of S2R+ cells treated with RNAi against different members of the SWH network and probed for P-Ser168 Yki (P-Yki), pan-Yki, Kibra, and Tubulin are shown (the anti-Kibra blot was performed on a parallel run of the same samples). The bottom panel shows efficiency of the *ex* dsRNAi treatment.\
(E) Western blots of co-IP assays between Wts-Flag and different versions of Myc-tagged Kibra are shown.\
(F) Endogenous co-IP assays between Yki and Wts in control S2 cells and in cells treated with *ex* and/or *kibra* RNAi are shown. The anti-Wts input blot was performed on a parallel run of the same samples. See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}
